Cirrhotic cardiomyopathy- Survival at 3 months after liver transplantation
Background: Cirrhotic cardiomyopathy (CCM) occurs in 39.4%–48.3% of patients with chronic liver disease with or without decompensation. A significant number of patients are likely to be listed for liver transplantation (LT). The early outcome of LT in these patients is not known. Aims and Objectives...
Main Authors: | Ravikumar Bokarvadia, Mayank Jain, Joy Varghese, Jayanthi Venkataraman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Transplantation |
Subjects: | |
Online Access: | http://www.ijtonline.in/article.asp?issn=2212-0017;year=2019;volume=13;issue=2;spage=91;epage=95;aulast=Bokarvadia |
Similar Items
-
Cirrhotic cardiomyopathy and liver transplantation
by: Yu. O. Malinovskaya, et al.
Published: (2016-09-01) -
Incidence and risk factors for mortality in patients with cirrhosis awaiting liver transplantation
by: Mayank Jain, et al.
Published: (2019-01-01) -
Cirrhotic cardiomyopathy: the liver affects the heart
by: M.V.H. Carvalho, et al.
Published: (2019-02-01) -
Cardiovascular manifestation of end-stage liver disease and perioperative echocardiography for liver transplantation: anesthesiologist’s view
by: Sangbin Han, et al.
Published: (2022-04-01) -
Management of Hepatitis B Virus Infection in Liver Transplant Recipients
by: Joy Varghese, et al.
Published: (2013-12-01)